Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baijin Life Science HoldingsMNNGF 33 Graham Number is $0.02 as of Sep. 2025, which is 99% below its 10-year median of 3.11. GuruFocus rates MNNGF with a GF Score™ of 33/100 and a GF Value™ of $0.05. The stock has 4 warning signs investors should review. Among 760 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 131578.82% on this metric.
Graham Number is a figure that measures a stock's fundamental value by taking into account the company's earnings per share and book value per share. The Graham number is the upper bound of the price range that a defensive investor should pay for the stock. According to the theory, any stock price below the Graham number is considered undervalued, and thus worth investing in.
The historical rank and industry rank for Baijin Life Science Holdings's Graham Number or its related term are showing as below:
During the past 13 years, the highest Price to Graham Number ratio of Baijin Life Science Holdings was 5.55. The lowest was 2.00. And the median was 3.11.
MNNGF's Price-to-Graham-Number is not ranked *
in the Retail - Cyclical industry.
Industry Median: 1.23 * Ranked among companies with meaningful Price-to-Graham-Number only.
Graham Number is a combination of asset valuation and earnings power valuation. It is a very conservative way of valuing a stock.
Baijin Life Science Holdings (OTCPK:MNNGF) Graham Number Explanation
Ben Graham actually did not publish a formula like this. But he wrote in The Intelligent Investor (1948 version) regarding to the criteria for purchases:
Current price should not be more than 15 times average earnings of the past three years.
Current price should not be more than 1.5 times the book value last reported. However, a multiplier of earnings below 15 could justify a correspondingly higher multiplier of assets. As a rule of thumb we suggest that the product of the multiplier times the ratio of price to book value should not exceed 22.5. (This figure corresponds to 15 times earnings and 1.5 times book value. It would admit an issue selling at only 9 times earnings and 2.5 times asset value, etc.)
Unlike valuation methods such as DCF or Discounted Earnings, the Graham number does not take growth into the valuation. Unlike the valuation methods based on book value alone, it takes into account the earnings power. Therefore, the Graham Number is a combination of asset valuation and earnings power valuation.
In general, the Graham number is a very conservative way of valuing a stock. It cannot be applied to companies with negative book values.
Baijin Life Science Holdings's Price to Graham number Ratio for today is calculated as
Price to Graham number
=
Share Price (Today)
/
Graham number (Q: Sep. 2025 )
=
0.08
/
N/A
=
N/A
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Please keep these in mind:
1. Graham Number does not take growth into account. Therefore it underestimates the values of the companies that have good earnings growth. We feel that if the earnings per share grows more than 10% a year, Graham Number underestimates the value.
2. Graham Number punishes the companies that have temporarily low earnings. Therefore, an average of earnings makes more sense in the calculation of Graham Number.
3. Graham Numbers underestimates companies that are light with book.
Baijin Life Science Holdings Graham Number Related Terms
Baijin Life Science Holdings Graham Number Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Luxury Goods subindustry, Baijin Life Science Holdings's Price-to-Graham-Number, along with its competitors' market caps and Price-to-Graham-Number data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baijin Life Science Holdings Price-to-Graham-Number vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Price-to-Graham-Number distribution charts can be found below:
* The bar in red indicates where Baijin Life Science Holdings's Price-to-Graham-Number falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baijin Life Science Holdings (MNNGF) has a Graham Number of $0.02 as of Sep. 2025. The Graham Number values a company based on its per-share earnings and book value. View historical data on Baijin Life Science Holdings and its competitors. This is 99% below median its historical median of 3.11. Over the past decade, Baijin Life Science Holdings' Graham Number has ranged from 2.00 to 5.55. According to the industry distribution chart, Baijin Life Science Holdings ranks #999999 out of 760 companies in the Retail - Cyclical industry.
Is Baijin Life Science Holdings' Graham Number too high?
Baijin Life Science Holdings' current Graham Number of $0.02 is 99% below median its 10-year median of 3.11. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 5.55. The Retail - Cyclical industry median Graham Number is 1.23. Baijin Life Science Holdings' value of $0.02 is 98.4% below this industry median. Based on the distribution chart, Baijin Life Science Holdings ranks #999999 out of 760 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Graham Number compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #999999 out of 760 companies for Graham Number. This places Baijin Life Science Holdings in the lower half of its industry. The industry median Graham Number is 1.23. Baijin Life Science Holdings' value of $0.02 is 98.4% below this benchmark. Historically, Baijin Life Science Holdings' own Graham Number has ranged from 2.00 to 5.55 over the past decade. While the company's 10-year median is 3.11 vs. the industry median of 1.23, Baijin Life Science Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Graham Number for a Retail - Cyclical company?
The median Graham Number among Retail - Cyclical companies is 1.23, based on 760 companies in the industry. Companies in the top quartile (top 25%) have a Graham Number significantly above this median, while those in the bottom quartile fall well below. However, Graham Number should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baijin Life Science Holdings's current Graham Number of $0.02 is 98.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Graham Number mean?
A high Graham Number can signal that a stock is expensive relative to its fundamentals. The Graham Number values a company based on its per-share earnings and book value. View historical data on Baijin Life Science Holdings and its competitors. For the Retail - Cyclical industry, the median Graham Number is 1.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baijin Life Science Holdings's current Graham Number is $0.02, which is 99% below median its own 10-year median of 3.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Graham Number of $0.02. The stock's GF Value™ is $0.05, compared to a current price of $0.08 — trading 60% above its estimated fair value. The current Graham Number is $0.02, which is 99% below median its 10-year median of 3.11 and 98.4% below the Retail - Cyclical industry median of 1.23. Baijin Life Science Holdings' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Graham Number calculated?
Graham Number is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Graham Number is $0.02 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?
Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued.
The current stock price of $0.08 is trading 60% above its estimated GF Value™ of $0.05.
Key valuation signals for MNNGF:
Graham Number: $0.02 (99% below median its 10-year median of 3.11)
GF Value™: $0.05 vs. price of $0.08 (60% above fair value)
Industry Position: 98.4% below the Retail - Cyclical median (#999999 of 760)
No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
33GF Score
Get the complete analysis for MNNGF
Graham Number is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MNNGF has been successfully added to your 
